Rank #1: The Growing Burden of HPV-Associated Cancers
Valid until: 19-07-2020
Claim your CME credit at https://reachmd.com/programs/cme/the-growing-burden-of-hpv-associated-cancers/10850/
As the burden of HPV-associated cancers like cervical cancer and oropharyngeal cancers, which are a subset of squamous cell cancer of the head and neck (SCCHN), continues to grow, are there emerging treatments that may lead to more optimal outcomes? Join oncology experts in both areas of focus as they discuss treatment approaches for SCCHN and cervical cancer.
Jul 19 2019
Rank #2: Advances in Aesthetic Medicine: PLLA Technique Demonstration
Valid until: 10-03-2021
Claim your CME credit at https://reachmd.com/programs/cme/advances-aesthetic-medicine-plla-technique-demonstration/11290/
Physical appearance can have a direct impact on a patient’s self-image and quality of life. To help patients, aesthetic clinicians must be able to perform a comprehensive facial analysis and work with the patient to establish realistic goals and expectations of aesthetic treatments. That’s why treatment selection should be based on a thorough understanding of the various therapies available, their mechanisms of action, product characteristics, as well as the administration techniques required.
This demonstration video reviews the important factors that guide optimal product selection, treatment placement, and injection techniques. Also discussed is the importance of and the techniques for meticulous product preparation and performance of advanced injection techniques, including sequencing and layering.
Mar 10 2020
Rank #3: How to Approach Liquid Biopsy in the Treatment of NSCLC
Valid until: 29-04-2021
Claim your CME credit at https://reachmd.com/programs/cme/how-approach-liquid-biopsy-treatment-nsclc/11275/
Learn insightful information around the treatment of non-small cell lung cancer (NSCLC) with thoughtful consideration of novel sampling applications, genomic mutations, and resistance mechanisms.
Apr 30 2020
Rank #4: PLLA: The Right Patient at the Right Time
Valid until: 20-03-2021
Claim your CME credit at https://reachmd.com/programs/cme/plla-the-right-patient-at-the-right-time/11310/
Determining which patients will benefit from biostimulant injections and which will benefit from surgery is an important consideration for aesthetic clinicians. This discussion addresses the specific factors that can help guide optimal product selection, administration techniques, and sequencing.
Mar 20 2020
Rank #5: Emerging Considerations in Triple-Negative Breast Cancer: Focus on Immunotherapy
Valid until: 01-11-2020
Claim your CME credit at https://reachmd.com/programs/cme/emerging-considerations-triple-negative-breast-cancer-focus-immunotherapy/11031/
Immunotherapy-based combination approaches are changing the standard of care for certain patients with triple-negative breast cancer. Dr. Sara Hurvitz and Dr. Tiffany Traina are here to discuss these advances in treatment and what they mean for patient care.
Nov 01 2019
Rank #6: Family Planning with MS: Closing the Gaps
Valid until: 03-11-2020
Claim your CME credit at https://reachmd.com/programs/cme/family-planning-with-ms-closing-the-gaps/10778/
Both male and female patients with multiple sclerosis (MS) face many questions and concerns when starting a family. And since this rapidly advancing area often leads to challenging questions for and from patients, this activity reviews case scenarios often faced by healthcare professionals when treating and counseling their patients with MS.
Nov 04 2019
Rank #7: Keys to Detecting COPD in the Primary Care Setting
Valid until: 02-11-2020
Claim your CME credit at https://reachmd.com/programs/cme/keys-to-detecting-copd-in-the-primary-care-setting/10940/
Due to comorbidities that often complicate the diagnosis of chronic obstructive pulmonary disease (COPD), this complex disease can often be missed in the clinic. To stress the importance of early recognition and to share their experiences with diagnosing and managing COPD, Dr. Jennifer Caudle is joined by Chief Science Officer for the COPD Foundation and primary care physician Dr. Barbara Yawn, Chief Medical Officer for the COPD Foundation and pulmonologist Dr. Byron Thomashow, and Mr. Doug Martin, a patient with COPD.
Nov 02 2019
Rank #8: Expert Answers to Common Questions for the Management of Hemophilia A
Valid until: 10-07-2020
Claim your CME credit at https://reachmd.com/programs/cme/expert-answers-common-questions-management-hemophilia/10839/
Hemophilia A is a rare bleeding disorder caused by deficiency of clotting factor VIII. The current standard of care for patients with severe hemophilia A centers on replacement therapy with factor VIII concentrate, either on demand when bleeding occurs or prophylactically (replacement therapy). Potential complications from replacement therapy include the development of inhibitory antibodies that attack the clotting factor in approximately one-fourth of patients, viral infections from human clotting factors, and bleeding in joints and muscles resulting from treatment delays. According to treatment guidelines from the Medical and Scientific Advisory Council (MASAC), “Inhibitor development is the most severe complication of treatment for patients with inherited hemophilia A.” In addition, the high cost and frequency of infusing factor VIII concentrates can increase the potential for side effects, thereby negatively affecting patient quality of life.
Fortunately, several unique agents have been newly approved or are currently under development. These agents promise to reduce morbidity and improve quality of life for patients. Clinicians will be challenged to integrate these new agents into their clinical practices.
AXIS routinely collects and analyzes data gathered from participants in our live grand rounds programs. These questions provide incredible insight regarding the persistent challenges that clinicians face when ...
Jul 11 2019
Rank #9: Early Recognition of Acute Kidney Injury: What’s the Role of Biomarkers?
Valid until: 13-03-2021
Claim your CME credit at https://reachmd.com/programs/cme/early-recognition-of-acute-kidney-injury-whats-the-role-of-biomarkers/11222/
Acute kidney injury (AKI) is a common problem faced by both nephrologists and intensivists as well as surgeons and general practitioners. AKI is increasing in hospitalized patients, and since it’s associated with both short- and long-term adverse outcomes, early recognition of patients who are at an increased risk for developing AKI is essential if we are to effectively intervene and provide optimal outcomes. Fortunately, recent data suggests that certain biomarkers can help us in clinical decision making with regard to AKI—which is the focus of this discussion.
Mar 13 2020
Rank #10: Insights from the Latest Clinical Trials in Lung Cancer
Valid until: 10-01-2021
Claim your CME credit at https://reachmd.com/programs/cme/insights-from-the-latest-clinical-trials-in-lung-cancer/11161/
In spite of the available evidence supporting the critical need for molecular testing to help determine which treatment is best for patients with non-small cell lung cancer, better strategies are needed to change how and when molecular testing occurs in the diagnostic journey. To help overcome this challenge as well as the challenges related to the initiation and sequencing of treatment with immunotherapies and TKIs in patients with lung cancer, Drs. Mark A. Socinski and Tarek M. Mekhail sit down together to dive into the latest insights from the 2019 ESMO Asia Congress.
Jan 10 2020
Rank #11: Glycemic Control in T2DM: Opportunities and Challenges
Valid until: 04-11-2020
Claim your CME credit at https://reachmd.com/programs/cme/glycemic-control-in-t2dm-opportunities-and-challenges/11016/
In addition to suboptimal glycemic control, cardiovascular events and obesity are also associated with a risk for T2DM and often correlate with poor outcomes. This discussion will focus on how we can use the available treatment options to improve overall outcomes for our patients with diabetes.
Nov 05 2019
Rank #12: Global Facial Rejuvenation Practice Updates
Valid until: 20-03-2021
Claim your CME credit at https://reachmd.com/programs/cme/global-facial-rejuvenation-practice-updates/11309/
Since physical appearance can have a major impact on a patient’s self-image and quality of life, it’s not uncommon for patients to seek out facial rejuvenation treatments—which is where aesthetic clinicians come into play. To ensure patients are being provided with the best course of action possible, clinicians first need to understand the importance of completing a thorough facial analysis, as well as the factors that can help guide optimal product selection, administration techniques, and appropriate combination approaches. That’s why this activity takes an in-depth look at these topics and more.
Mar 20 2020
Rank #13: HIV Can Be Prevented—Are You Doing Your Part?
Valid until: 29-10-2020
Claim your CME credit at https://reachmd.com/programs/cme/hiv-can-be-prevented-are-you-doing-your-part/10993/
More than 1.1 million Americans are living with HIV, and yet 162,500 are unaware of their diagnosis. With 40 percent of new infections being transmitted by people who are living with undiagnosed HIV, providers can have an effect on decreasing that rate by increasing testing and education and by identifying patients who are candidates for preexposure prophylaxis (PrEP).
Oct 29 2019
Rank #14: Taking Care of Yourself While Taking Care of Others During COVID-19
Valid until: 10-04-2021
Claim your CME credit at https://reachmd.com/programs/cme/taking-care-yourself-while-taking-care-others-during-covid-19/11406/
Due to the COVID-19 pandemic, healthcare providers are facing unprecedented stressors at work and at home that are taking a toll on their well-being. Join Dr. Nicole Washington, a board-certified psychiatrist who focuses on healthcare provider mental health, as she discusses different methods to cope with the fear, struggles, and challenges associated with COVID-19. Learn about strategies for mindfulness and de-stressing as well as the benefits of speaking to a colleague or mental health professional directly or through a multitude of online resources.
Apr 10 2020
Rank #15: COVID-19: Interim Guidance on Management Pending Empirical Evidence. From an American Thoracic Society-led International Task Force
Valid until: 09-04-2021
Claim your CME credit at https://reachmd.com/programs/cme/covid-19-interim-guidance-management-pending-empirical-evidence-american-thoracic-society/11408/
There is little empirical evidence to guide the management of COVID-19. However, with new cases being confirmed daily and the rate still increasing, clinicians taking care of patients with COVID-19 need guidance now. That’s why, with the support of the American Thoracic Society, an international task force of clinicians from academic centers on the frontline of COVID-19 management was convened to develop interim consensus guidance which will be reevaluated as evidence accumulates. This program provides a summary of that guidance to date.Please click here to access COVID-19 Clinical Resources for Clinicians.
Apr 09 2020
Rank #16: Telemedicine During COVID-19 Outbreak
Valid until: 07-04-2021
Claim your CME credit at https://reachmd.com/programs/cme/telemedicine-during-covid-19-outbreak/11393/
Tune in as Drs. Suneet Mittal from the Valley Health System in New Jersey and Aysha Arshad from Carient Heart and Vascular in Virginia discuss how telemedicine has been utilized in their practices during the COVID-19 pandemic and how you can make telemedicine work in your own practice.
Apr 07 2020
Rank #17: How Primary Care Clinicians on the Frontline Are Managing Patients During the COVID-19 Pandemic
Valid until: 06-04-2021
Claim your CME credit at https://reachmd.com/programs/cme/how-primary-care-clinicians-frontline-are-managing-patients-during-covid-19-pandemic/11395/
Outpatient, community-based primary care practices are being impacted in a variety of ways by the COVID-19 pandemic. Join Drs. Jennifer Caudle and Brian McDonough as they explore various methods they’ve used to maintain connections with their patients and fellow peers, what lessons they’ve learned from telemedicine, and how primary care clinicians can ensure that patients with chronic diseases continue to receive the regular care they need to avoid adverse outcomes.
Apr 06 2020
Rank #18: COVID-19 & Cardiovascular Considerations
Valid until: 04-04-2021
Claim your CME credit at https://reachmd.com/programs/cme/covid-19-cardiovascular-considerations/11392/
Tune in as Drs. C. Michael Gibson and Deepak Bhatt from the Harvard Medical School discuss their experiences managing patients with cardiovascular disease during the COVID-19 pandemic along with the evidence that’s been accumulated about the interplay between COVID-19 and cardiovascular disease.
Apr 04 2020
Rank #19: Atopic Dermatitis: The Clinical Art of Diagnosis with Attention to Comorbidities
Valid until: 12-08-2020
Claim your CME credit at https://reachmd.com/programs/cme/atopic-dermatitis-the-clinical-art-of-diagnosis-with-attention-to-comorbidities/10849/
There are many challenges clinicians face when diagnosing atopic dermatitis, but reaching an accurate diagnosis is essential in not only beginning treatment sooner, but also in managing its comorbidities. Joining Dr. Jennifer Caudle are allergist Dr. Anna Fishbein and dermatologist Dr. Lindsay Strowd, who use a patient case to demonstrate their approach to diagnosing atopic dermatitis.
Aug 12 2019
Rank #20: Because You Care About Your Patients With ROS1+ NSCLC: Recent Revolutions in Treatment
Valid until: 29-03-2021
Claim your CME credit at https://reachmd.com/programs/cme/because-you-care-about-your-patients-with-ros1-nsclc-recent-revolutions-in-treatment/11292/
The discovery of predictive biomarkers, including ROS1 rearrangements, has led to an improvement in overall survival and progression-free survival in non–small cell lung cancer (NSCLC) by identifying subgroups of patients who benefit from targeted treatment. First-line therapy options for ROS1 rearrangement–positive metastatic NSCLC now include crizotinib, entrectinib, and ceritinib, with the NCCN recommending crizotinib and entrectinib as preferred agents. Additional agents are being studied to improve treatment outcomes of patients with ROS1 rearrangement–positive NSCLC that becomes resistant to available therapies.
This activity reviews the most recent clinical data and evidence-based updates and provides expert insights on the treatment of ROS1+ metastatic NSCLC.
Mar 30 2020